Substance Use DisordersNCT06310668
Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?
A study testing group cognitive behavioral therapy sessions in people with Substance Use Disorders, run by Egyptian Medical Syndicate at 1 site in Egypt.
Trial summary
Aim of the study: In this study, the change in emotional intelligence will be assessed before and after group CBT sessions in male patients with substance use disorder in the inpatient department of the addiction unit at Mansoura University Hospital. Read more about this study
- Who is it for?
- Ages 18 to 55 years, men only
- Conditions the study is for
- Substance Use Disorders
- What is being tested?
- group cognitive behavioral therapy sessions
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 84 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Apr 2024to 20 Oct 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 55 years
- Men only
- No healthy volunteers
- Adult
Who may be able to join
- Male patients with DSM5 diagnosis of substance use disorder
- Age range 18 to 55 years
- Agreeing to participate in the research and giving written informed consent
- Average IQ as evidenced by the Wechsler Adult Intelligence scale
Who cannot join
- Psychiatric comorbidities
- Any neurological or medical conditions interfering with the cognitive abilities
- 4-Illiterate patients
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Addiction Unit, Psychiatry Department, Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, 57357
About this study
Official title: Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?: A Randomized Clinical Trial
Aim of the study: In this study, the change in emotional intelligence will be assessed before and after group CBT sessions in male patients with substance use disorder in the inpatient department of the addiction unit at Mansoura University Hospital.
Read the detailed description
Between the ages of fifteen and sixty-four, 5% of the global population, or nearly 200 million people, reported consuming at least one illegal substance per year. According to the 2008 World Drug Report, cannabis has a prevalence of 3.8%, compared to 0.6% for amphetamines and opiates, 0.3% for cocaine and heroin, and 0.2% for ecstasy. A cross-sectional study by [1] in Egypt with 2552 participants found that sedatives (8.7%) were the most commonly abused drugs, followed by alcohol (6.7%), cannabinoids (6.6%), and tramadol (2.4%). The prevalence of drug use was 8.9% for cigarette smoking followed by sedatives (4.3%), hashish (3.6%), alcohol (2.7%), cannabinoids (1.4%,) and tramadol (1.0%).
Lander et al. [2] believed that substance use disorder (SUD) is one of the most severe psychosocial traumas posing environmental, psychological, behavioral, and emotional challenges to individuals. It can cause obstacles for persons, families, and cultural foundations, endangering countries' dynamics. SUD is a brain disorder that impacts the person's behavior, manifests as psychological and physiological symptoms; and persists for a long duration despite its harmful and detrimental consequences.
Previous research has shown that different factors impact starting and following addiction. These factors are; 1) Individuals, such as the presence or lack of personality traits that make an individual vulnerable to addiction, for example, non-assertiveness as an individual factor. 2) Social factors, such as parental addiction, lack of parental control, availability of substances, presence of addicted peers, and so on [3].
Emotional intelligence (EQ) is a relatively recent behavioral model rising to prominence with Daniel Goleman's 1995 Book called 'Emotional Intelligence'. The early emotional intelligence theory was originally developed during the 1970s and 80s by the work and writings of psychologists Howard Gardner (Harvard), Peter Salovey (Yale), and John 'Jack' Mayer (New Hampshire) [4]. Emotional intelligence consists of the ability to motivate individuals such as endurance against frustration, impulse control, mood modification, and avoiding destructive stress to prevent mental disorders [5].
Emotional intelligence is a set of non-cognitive skills and abilities that can help a person deal with environmental stressors, according to [6]. Azzam and Elghonemy's [7] research demonstrated that emotional regulation was associated with mood improvement and a higher likelihood of SUD recovery. They found emotional intelligence to be an important factor in the treatment of substance use. [8] suggested that improvements in EI through treatment interventions can be an effective way to improve not only EI but also psychiatric symptoms both for the short term and the long term after rehabilitation.
- Conditions
- Substance Use Disorders
- Being tested
- group cognitive behavioral therapy sessions
- Medical subject headings
- Substance-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
group cognitive behavioral therapy sessionsBehavioural
12 group CBT sessions based on catching and challenging cognitive errors and behavioral techniques to deal with substance use problems
| Study group | Role | What they receive |
|---|---|---|
| CBT intervention arm | Experimental | patients with substance use disorder in the inpatient department of the addiction unit in Mansoura University Hospital who will receive group CBT sessions Receives: Behavioral: group cognitive behavioral therapy sessions |
| NON-CBT control arm | No intervention | age and gender-matched patients with substance use disorder in the outpatient clinics of the addiction unit in Mansoura University Hospital who will not receive group CBT sessions |
What is being measured
The primary outcome is the main question the study is designed to answer.
emotional intelligence
Trait Emotional Intelligence Questionnaire (TEIQue-SF):
The Trait Emotional Intelligence Scale (Petrides, 2009b) includes 30 items that assess the following four factors: well-being, self-control, sociability (each with six items), and emotionality (eight items), as well as four additional items 3, 14, 18, and 29, which do not belong to any factor and directly contribute to the evaluation of the overall degree of the trait emotional intelligence, as indicated by the scoring key. The questionnaire is graded on a seven-point Likert scale, with responses ranging from 1 (strongly disagree) to 7 (strongly agree), with higher scores indicating higher emotional intelligence. This TEIQue-SF scale has been used in numerous studies (Cooper \& Petrides, 2010; Perera, 2015) owing to its good psychometric properties. The Arabic version was validated by Al-Dassean, (2023).
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Mar 2024
- Study start1 Apr 2024
- Primary completion20 Sep 2024
- Study completion20 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Substance Use DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- randomized clinical trial
- Masking
- None (open label)
- Enrolment
- 84 participants (actual)
Sponsor and investigators
- Lead sponsor
- Egyptian Medical Syndicate
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hassan Mohammed Sonbol, Egyptian Medical Syndicate
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06310668
- Sponsor's protocol ID
- CBT IN substance use disorder
- Status last verified
- Feb 2025
- First submitted
- 5 Mar 2024
- Last updated
- 25 Feb 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Kabbash I, Zidan O, Saied S. Substance abuse among university students in Egypt: prevalence and correlates. East Mediterr Health J. 2022 Jan 31;28(1):31-40. doi: 10.26719/emhj.22.001.
PubMed 35165876Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health. 2013;28(3-4):194-205. doi: 10.1080/19371918.2013.759005.
PubMed 237314143-Sho'aKazemi M. The comparative analysis of the relationship between coping strategies and attitude toward drug addicts (Persian). Addiction Studies; 2008.
4-Nazari K, Emami M. Emotional Intelligence: Understanding, applying, and measuring. Journal of Applied Sciences Research. 2012;8(3):1594-1607.
5-Bar-on R. The Emotional Quotient Inventory (EQ-i). A Test of Emotional Intelligence. Jossey. Bass; 2006.
6-Shareh, H., & Foshtanqi, K. (2019). The role of emotional intelligence and marital satisfaction in women's quality of life: Structural equation modeling. Journal of Fundamentals of Mental Health, 21(2), 109-120.
7-Azzam H, Elghonemy S. Emotional intelligence and substance abuse: A possible relation. Current Psychiatry. 2008; 15:113.25.
8-Henning, C., Crane, A. G., Taylor, R. N., & Parker, J. D. (2021). Emotional intelligence: relevance and implications for addiction. Current Addiction Reports, 8, 28-34.
Study at a glance
From the registry record, last updated by the sponsor on 25 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Has CBT an Effect on Emotional Intelligence in Patients With Substance Use Disorder?: A Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT06310668
- Acronym / sponsor ID
- CBT IN substance use disorder
- Conditions
- Substance Use Disorders
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 84 participants (actual)
- Lead sponsor
- Egyptian Medical SyndicateUniversity, hospital or other
- Study start
- 1 Apr 2024 (actual)
- Primary completion
- 20 Sep 2024 (actual)
- Study completion
- 20 Oct 2024 (actual)
- First posted
- 15 Mar 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Aim of the study: In this study, the change in emotional intelligence will be assessed before and after group CBT sessions in male patients with substance use disorder in the inpatient department of the addiction unit at Mansoura University Hospital.
Detailed description
Between the ages of fifteen and sixty-four, 5% of the global population, or nearly 200 million people, reported consuming at least one illegal substance per year. According to the 2008 World Drug Report, cannabis has a prevalence of 3.8%, compared to 0.6% for amphetamines and opiates, 0.3% for cocaine and heroin, and 0.2% for ecstasy. A cross-sectional study by [1] in Egypt with 2552 participants found that sedatives (8.7%) were the most commonly abused drugs, followed by alcohol (6.7%), cannabinoids (6.6%), and tramadol (2.4%). The prevalence of drug use was 8.9% for cigarette smoking followed by sedatives (4.3%), hashish (3.6%), alcohol (2.7%), cannabinoids (1.4%,) and tramadol (1.0%).
Lander et al. [2] believed that substance use disorder (SUD) is one of the most severe psychosocial traumas posing environmental, psychological, behavioral, and emotional challenges to individuals. It can cause obstacles for persons, families, and cultural foundations, endangering countries' dynamics. SUD is a brain disorder that impacts the person's behavior, manifests as psychological and physiological symptoms; and persists for a long duration despite its harmful and detrimental consequences.
Previous research has shown that different factors impact starting and following addiction. These factors are; 1) Individuals, such as the presence or lack of personality traits that make an individual vulnerable to addiction, for example, non-assertiveness as an individual factor. 2) Social factors, such as parental addiction, lack of parental control, availability of substances, presence of addicted peers, and so on [3].
Emotional intelligence (EQ) is a relatively recent behavioral model rising to prominence with Daniel Goleman's 1995 Book called 'Emotional Intelligence'. The early emotional intelligence theory was originally developed during the 1970s and 80s by the work and writings of psychologists Howard Gardner (Harvard), Peter Salovey (Yale), and John 'Jack' Mayer (New Hampshire) [4]. Emotional intelligence consists of the ability to motivate individuals such as endurance against frustration, impulse control, mood modification, and avoiding destructive stress to prevent mental disorders [5].
Emotional intelligence is a set of non-cognitive skills and abilities that can help a person deal with environmental stressors, according to [6]. Azzam and Elghonemy's [7] research demonstrated that emotional regulation was associated with mood improvement and a higher likelihood of SUD recovery. They found emotional intelligence to be an important factor in the treatment of substance use. [8] suggested that improvements in EI through treatment interventions can be an effective way to improve not only EI but also psychiatric symptoms both for the short term and the long term after rehabilitation.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- randomized clinical trial
| Arm | Type | Receives |
|---|---|---|
| CBT intervention arm | Experimental | Behavioral: group cognitive behavioral therapy sessionspatients with substance use disorder in the inpatient department of the addiction unit in Mansoura University Hospital who will receive group CBT sessions |
| NON-CBT control arm | No intervention | –age and gender-matched patients with substance use disorder in the outpatient clinics of the addiction unit in Mansoura University Hospital who will not receive group CBT sessions |
Who may qualify
- Ages
- 18 to 55 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Male patients with DSM5 diagnosis of substance use disorder
- Age range 18 to 55 years
- Agreeing to participate in the research and giving written informed consent
- Average IQ as evidenced by the Wechsler Adult Intelligence scale
Key exclusion criteria (3 listed)
- Psychiatric comorbidities
- Any neurological or medical conditions interfering with the cognitive abilities
- 4-Illiterate patients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| group cognitive behavioral therapy sessions12 group CBT sessions based on catching and challenging cognitive errors and behavioral techniques to deal with substance use problems | Behavioural | CBT intervention arm |
Primary outcome
emotional intelligence
Time frame: 6 months
Trait Emotional Intelligence Questionnaire (TEIQue-SF): The Trait Emotional Intelligence Scale (Petrides, 2009b) includes 30 items that assess the following four factors: well-being, self-control, sociability (each with six items), and emotionality (eight items), as well as four additional items 3, 14, 18, and 29, which do not belong to any factor and directly contribute to the evaluation of the overall degree of the trait emotional intelligence, as indicated by the scoring key. The questionnaire is graded on a seven-point Likert scale, with responses ranging from 1 (strongly disagree) to 7 (strongly agree), with higher scores indicating higher emotional intelligence. This TEIQue-SF scale has been used in numerous studies (Cooper \& Petrides, 2010; Perera, 2015) owing to its good psychometric properties. The Arabic version was validated by Al-Dassean, (2023).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Feb 2025.
- Background: PubMed 35165876Kabbash I, Zidan O, Saied S. Substance abuse among university students in Egypt: prevalence and correlates. East Mediterr Health J. 2022 Jan 31;28(1):31-40. doi: 10.26719/emhj.22.001.
- Background: PubMed 23731414Lander L, Howsare J, Byrne M. The impact of substance use disorders on families and children: from theory to practice. Soc Work Public Health. 2013;28(3-4):194-205. doi: 10.1080/19371918.2013.759005.
- Background3-Sho'aKazemi M. The comparative analysis of the relationship between coping strategies and attitude toward drug addicts (Persian). Addiction Studies; 2008.
- Background4-Nazari K, Emami M. Emotional Intelligence: Understanding, applying, and measuring. Journal of Applied Sciences Research. 2012;8(3):1594-1607.
- Background5-Bar-on R. The Emotional Quotient Inventory (EQ-i). A Test of Emotional Intelligence. Jossey. Bass; 2006.
- Background6-Shareh, H., & Foshtanqi, K. (2019). The role of emotional intelligence and marital satisfaction in women's quality of life: Structural equation modeling. Journal of Fundamentals of Mental Health, 21(2), 109-120.
- Background7-Azzam H, Elghonemy S. Emotional intelligence and substance abuse: A possible relation. Current Psychiatry. 2008; 15:113.25.
- Background8-Henning, C., Crane, A. G., Taylor, R. N., & Parker, J. D. (2021). Emotional intelligence: relevance and implications for addiction. Current Addiction Reports, 8, 28-34.
Related trials for Substance Use Disorders
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Enrolling by invitationObservational study
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Substance Use Disorders (SUDs)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing group cognitive behavioral therapy sessions in people with Substance Use Disorders, run by Egyptian Medical Syndicate at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
emotional intelligence (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06310668, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2025.